Includes a Special Event:
Conversations with the President: Scientific Excellence and the Common Good
Join us for this specially planned day for students interested in biology, chemistry, computer science, kinesiology, physics, health professions or 3-2 engineering. In addition to connecting with faculty and students from the Science Division, you will hear from President Lindsay and influential leaders of science and technology.
Date:
| Fall 2012 | ![]() |
Science Experience Day Schedule
Final schedule available upon arrival
| 8:30 a.m. | Check-in/Welcome, Ken Olsen Science Center Lobby |
| 9:10 a.m. | Visit a Class |
| 10:25 a.m. | Science Center Tour |
| 11:30 a.m. | Conversations with the President: Scientific Excellence and the Common Good and Luncheon |
| 1 p.m. | Interactive Science Lab (several options available based on major of interest) |
| 2:40 p.m. | Admissions interview (high school seniors/transfers) or Campus Tour |
Conversations with the President: Scientific Excellence and the Common Good
Gordon College presents its second event in the series, Conversations with the President, for students interested in the sciences. This conversation-style format hosted by Gordon President D. Michael Lindsay, offers firsthand insights from pioneers in the world of science.
Dr. Michael Lindsay recently completed the largest interview-based research study on leadership ever undertaken, featuring in-depth conversations with 550 leaders at the nation’s largest corporations, nonprofit and government organizations.
Dr. Christopher W. Kersey is a managing partner of Camden Partners, one of the largest growth equity investment management funds for health care and life science industries in the United States. Dr. Kersey has extensive international health services experience and is on the board of trustees at Johns Hopkins Hospital.
John Mendelsohn, M.D. served as the president of the University of Texas’ MD Anderson Cancer Center from 1996–2011 where he led 18,000 employees who served 100,000 patients each year. In 2004, he and his collaborators are known for developing the antibody for the treatment of colon cancer.
Rosalind W. Picard, Sc. D. is founder and director of the Affective Computing Research Group at the Massachusetts Institute of Technology (MIT) Media Laboratory and leader of the new and growing Autism & Communication Technology Initiative at MIT.